My hands shook as I texted my husband. I felt unmoored in my body, as if I’d awoken in a different house than the one where I ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

Actor and advocate Brooke Shields says learning how to embrace aging and prioritize preventive health in her 50s feels "like ...

EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients ...

NanoViricides, Inc. (NYSE American.:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, reports today that it has now obtained a right of first refusal ...

The rash associated with shingles usually crusts over within seven to 10 days for people with a healthy immune system and ...

If you experience lasting irritation and redness, sensitivity to light, or discharge from the eye, seek treatment right away ... Conditions like Lyme disease, measles, shingles or liver disease can ...

The US food and Drug Administration has approved lebrikizumab for treatment of atopic dermatitis in adults and children ages ...

The FDA approved lebrikizumab (Ebglyss) for treating atopic dermatitis in adults and children ages 12 years and up, drugmaker ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...

The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for ...